Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect Against Relapse After Myeloablative, HLA Matched Hematopoietic Cell Transplantation
PLoS ONE - United States
doi 10.1371/journal.pone.0158242
Full Text
Open PDFAbstract
Available in full text
Categories
Date
June 24, 2016
Authors
Publisher
Public Library of Science (PLoS)